Guardant Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated August 5, 2021, reports the issuance of a press release by Guardant Health, Inc. announcing financial results for the fiscal quarter ended June 30, 2021. The full text of the press release is included as Exhibit 99.1 and is incorporated by reference.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the referenced press release (Exhibit 99.1) rather than the body of this 8-K form.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period. It serves as a notification that the Q2 2021 results have been announced.
Guidance, Outlook, and Risks
Specific guidance, management commentary, risks, contingencies, or unusual items are not detailed in this filing text. Investors must refer to Exhibit 99.1 for the full press release content containing these disclosures.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2021 revenue and net loss figures.
- Verify year-over-year growth rates and gross margin trends in the referenced press release.
- Check for any updated full-year 2021 guidance provided in the press release.
- Confirm cash position and burn rate details from the full financial disclosure.